Paris-based start-up Nabla recently secured $24 million in Series B financing, led by Cathay Innovation and featuring participation from ZEBOX Ventures, the corporate venture capital fund of CMA CGM. This substantial investment will facilitate Nabla’s entrance into multiple industries, primarily focusing on developing advanced AI solutions to optimize supply chain and logistics operations. Additionally, CMA CGM will employ its expertise and network to help Nabla revolutionize the shipping industry by transforming decision-making processes and enhancing overall efficiency.
This development follows Nabla’s entry into a substantial agreement with Home Remote Monitoring Systems, an American healthcare giant Kaiser Permanente division. This partnership will integrate Nabla’s AI-powered digital health platform into Kaiser Permanente’s home monitoring systems, providing patients with a more comprehensive and personalized healthcare experience. The collaboration is anticipated to streamline remote healthcare, offering increased efficiency and convenience for healthcare providers and their patients.
Following this investment round, Nabla now has a valuation of $180 million. The company is currently working on an AI copilot designed to assist medical professionals in automatically creating clinical notes during consultations.
The founding team and company mission
Nabla was founded by Alexandre Lebrun, Delphine Groll, and Martin Raison, with Lebrun as the company’s CEO. This AI-driven solution aims to improve the accuracy and efficiency of documenting patient consultations while reducing the workload of medical staff and enhancing patient care. Nabla’s unique value proposition includes automating routine tasks, enabling healthcare providers to concentrate on diagnosing and treating patients.
Formerly, Lebrun held the CEO position at Wit.ai, an AI assistant start-up acquired by Facebook, after which he became the head of engineering at Facebook’s AI research lab FAIR.
Nabla’s live demonstration
A recent live demonstration of Nabla showcased the AI’s capabilities in a simulated patient consultation involving back pain. During the presentation, Nabla analyzed the patient’s symptoms, medical history, and related factors to provide a reasonable diagnosis and suggest appropriate treatment options. This impressive display highlights the potential for AI to revolutionize how doctors approach patient care by giving them access to essential information and enabling more informed decision-making.
In the demonstration, the doctor prompted Nabla’s interface to record the discussion, which was then converted into a written transcript after the consultation. This written transcript provided an accurate account of the conversation, ensuring that no important information was lost. Moreover, it allowed the doctor and patient to review their discussion later, promoting better understanding and adherence to the proposed treatment plan.
Using its medical data and language model, Nabla identified crucial information and generated a complete medical report within one to two minutes, featuring a summary, prescriptions, and follow-up appointment letters.
The purpose and benefits of Nabla Copilot
Nabla Copilot is designed to help doctors save time on administrative tasks rather than replace them, allowing physicians to focus more on patient care. By automating documentation and streamlining the report creation process, Nabla Copilot considerably lessens the time doctors spend on note-taking and report writing. This ultimately results in more efficient medical consultations, potentially improving patient outcomes and satisfaction.
As part of the company’s future plans, Nabla intends to seek FDA approval for clinical decision support and explore the possibility of level-five autonomous healthcare. This could potentially eliminate the need for doctors in specific situations, aiming to streamline patient care by integrating advanced technology and artificial intelligence for greater accessibility and efficiency. As these ambitious goals gradually materialize, the focus will be on ensuring patient safety and maintaining ethical standards throughout the implementation process.
Lebrun’s long-term vision
Lebrun envisions a future where doctors concentrate on empathy, surgical procedures, and crucial decision-making while AI handles diagnostics. This will enable medical professionals to dedicate their time and expertise to the more human aspects of healthcare, fostering stronger patient-doctor relationships. With AI handling diagnostics, doctors will have more information readily available to them, leading to better-informed decisions and improved patient outcomes.
FAQ Section
What was the purpose of Nabla’s latest funding round?
The recent $24 million Series B financing led by Cathay Innovation will help Nabla enter multiple industries, focusing on developing AI solutions for supply chain and logistics optimization. CMA CGM will also contribute to helping Nabla revolutionize the shipping industry.
What is the partnership between Nabla and Home Remote Monitoring Systems?
Nabla has partnered with Home Remote Monitoring Systems, a division of Kaiser Permanente, to integrate its AI-powered digital health platform into their home monitoring systems. This collaboration aims to streamline remote healthcare and provide a personalized experience for patients.
What does Nabla’s AI copilot do?
Nabla’s AI copilot aims to assist medical professionals in automatically creating clinical notes during consultations, improving the accuracy and efficiency of documenting patient sessions while reducing medical staff’s workload and enhancing patient care.
Who are the founders of Nabla?
Nabla was founded by Alexandre Lebrun, Delphine Groll, and Martin Raison, with Lebrun serving as the company’s CEO. Lebrun previously founded AI assistant start-up Wit.ai, which was acquired by Facebook, and later became the head of engineering at Facebook’s AI research lab FAIR.
What is Nabla Copilot’s purpose and benefits?
Nabla Copilot is designed to save doctors time on administrative tasks, allowing them to focus more on patient care. It automates documentation and streamlines report creation, resulting in more efficient medical consultations and improved patient outcomes and satisfaction.
What is Lebrun’s long-term vision for Nabla and the medical industry?
Lebrun envisions a future where doctors focus on empathy, surgical procedures, and crucial decision-making while AI handles diagnostics. This will allow medical professionals to dedicate their time to the more human aspects of healthcare, fostering stronger patient-doctor relationships and better-informed decisions leading to improved patient outcomes.
